Skip to main content
. Author manuscript; available in PMC: 2022 Feb 9.
Published in final edited form as: Prev Med. 2021 Feb 26;147:106483. doi: 10.1016/j.ypmed.2021.106483

Table 2:

Multivariable modified Poisson regression presented as Relative Risks (RRs) for higha allostatic load in US adults stratified by race/ethnicity and sex, by National Health and Examination Survey (NHANES) study period. Among 50,671 participants an estimated 1,056,925,341 US residents.

NHANES Period
1988 – 1991 1991 – 1994 1999 – 2002 2003 – 2006 2007 – 2010 2015 – 2018
Participants (N) 7,387 7,850 7,893 7,759 10,395 9,387
Estimated Nb (%)c 155,959,992 (14.76) 165,955,459 (15.70) 165,937,416 (15.70) 168,342,341 (15.93) 192,397,679 (18.20) 208,332,545 (19.71)
Presented as Adjusted Relative Risks (95% CI) d
Race/Ethnicity and Male Sex
 Non-Hispanic White 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent)
 Non-Hispanic Black 1.332 (1.331 – 1.334) 1.154 (1.153 – 1.155) 1.131 (1.130 – 1.133) 1.169 (1.168 – 1.171) 1.189 (1.188 – 1.190) 1.106 (1.105 – 1.107)
 Latino 1.228 (1.225 – 1.230) 1.072 (1.070 – 1.073) 1.038 (1.037 – 1.039) 1.297 (1.295 – 1.298) 1.220 (1.219 – 1.221) 1.259 (1.258 – 1.260)
 Other & Mixed-Race 0.932 (0.931 – 0.934) 0.909 (0.908 – 0.910) 1.527 (1.524 – 1.529) 1.105 (1.103 – 1.107) 1.146 (1.145 – 1.147) 1.120 (1.119 – 1.121)
Race/Ethnicity and Female Sex
 Non-Hispanic White 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent)
 Non-Hispanic Black 1.399 (1.397 – 1.401) 1.380 (1.379 – 1.381) 1.198 (1.197 – 1.200) 1.456 (1.455 – 1.458) 1.223 (1.221 – 1.224) 1.292 (1.290 – 1.293)
 Latina 1.316 (1.313 – 1.318) 1.255 (1.253 – 1.257) 1.048 (1.047 – 1.049) 1.206 (1.205 – 1.207) 1.191 (1.189 – 1.192) 1.266 (1.265 – 1.267)
 Other & Mixed-Race 1.154 (1.152 – 1.155) 1.183 (1.182 – 1.184) 1.180 (1.178 – 1.182) 1.144 (1.142 – 1.146) 1.001 (0.999 – 1.002) 1.158 (1.157 – 1.160)
Age Groups, in years
 18 – 29 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent) 1.000 (Referent)
 30 – 39 2.406 (2.403 – 2.409) 1.859 (1.857 – 1.861) 1.700 (1.698 – 1.701) 1.967 (1.965 – 1.969) 1.901 (1.900 – 1.903) 1.634 (1.632 – 1.635)
 40 – 49 4.596 (4.590 – 4.602) 2.986 (2.983 – 2.989) 2.513 (2.511 – 2.516) 2.905 (2.902 – 2.908) 2.243 (2.241 – 2.245) 2.198 (2.196 – 2.199)
 50 – 59 7.019 (7.010 – 7.028) 4.256 (4.252 – 4.260) 3.556 (3.552 – 3.560) 3.502 (3.498 – 3.506) 2.975 (2.973 – 2.978) 2.546 (2.544 – 2.548)
 60 – 69 8.052 (8.042 – 8.062) 4.698 (4.694 – 4.703) 3.900 (3.895 – 3.904) 3.759 (3.754 – 3.763) 3.329 (3.325 – 3.332) 2.545 (2.543 – 2.547)
 70+ 8.196 (8.185 – 8.207) 4.934 (4.929 – 4.939) 3.451 (3.447 – 3.455 3.328 (3.324 – 3.332) 3.024 (3.021 – 3.027) 2.539 (2.537 – 2.542)
a

High Allostatic load is defined as total Allostatic load score greater than or equal to 3 (presented as column percentages and standard errors). Allostatic load total score was calculated as sum total of components based on high-risk thresholds: albumin, BMI, C-reactive protein, creatinine clearance, diastolic blood pressure, glycated hemoglobin, systolic blood pressure, total cholesterol, and triglycerides.

b

Estimated using sampling weights from National Health and Nutrition Examination Survey (NHANES).

c

Presented as weighted row percentage, describes the total percentage of participants among all study periods.

d

Presented as Relative Risks and 95% confidence intervals for high allostatic load estimated using modified Poisson regression with robust variance estimation and accounting for NHANES weighting. Adjusted for race, gender, education, age groups, poverty-to-income ratio, smoking status, cancer, congestive heart failure, and heart attack.